Starling Oncology STLN
NASDAQ STLN
$5.94 -0.15 (-2.46%)
As of: Sep 3, 2026 · 2:49 PM EDT

Starling Oncology (STLN) Cost of Revenue (2021 - 2026)

Analysis

Starling Oncology (STLN) Cost of Revenue (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 HCA Healthcare 90.68 Bn 89.67 Bn 15.19 Bn 5.04 Bn
2 Tenet Healthcare 22.03 Bn 19.86 Bn 4.45 Bn 1.17 Bn
3 Encompass Health 12.07 Bn 11.93 Bn 1.34 Bn 254.90 Mn
4 Davita 11.73 Bn 11.05 Bn 1.16 Bn 2.39 Bn
5 Universal Health Services 10.15 Bn 10.01 Bn 3.29 Bn 1.35 Bn
6 Ensign 9.95 Bn 9.63 Bn 306.24 Mn 1.13 Bn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn 451.78 Mn
8 Pacs 6.68 Bn 6.51 Bn 338.46 Mn 1.09 Bn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn 413.93 Mn
10 Starling Oncology 613.04 Mn 571.94 Mn 27.17 Mn 134.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 134.12 Mn
Mar 31, 2026 124.13 Mn
Dec 31, 2025 -86.54 Mn
Sep 30, 2025 117.64 Mn
Jun 30, 2025 102.30 Mn
Mar 31, 2025 87.16 Mn
Dec 31, 2024 -66.90 Mn
Sep 30, 2024 85.54 Mn
Jun 30, 2024 46.52 Mn
Mar 31, 2024 49.50 Mn
Dec 31, 2023 48.36 Mn
Sep 30, 2023 44.96 Mn
Jun 30, 2023 44.88 Mn
Mar 31, 2023 42.81 Mn
Dec 31, 2022 38.38 Mn
Sep 30, 2022 36.13 Mn
Jun 30, 2022 32.88 Mn
Mar 31, 2022 27.38 Mn
Dec 31, 2021 27.35 Mn
Sep 30, 2021 25.39 Mn